(Q34720813)

English

Comparison of the prevalence of the poor metabolizer phenotype for CYP2D6 between 203 Hmong subjects and 280 white subjects residing in Minnesota*

scientific article published on July 1, 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Comparison of the prevalence of the poor metabolizer phenotype for CYP2D6 between 203 Hmong subjects and 280 white subjects residing in Minnesota (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Comparison of the prevalence of the poor metabolizer phenotype for CYP2D6 between 203 Hmong subjects and 280 white subjects residing in Minnesota* (English)

1 reference

10.1016/0009-9236(95)90069-1

https://api.crossref.org/works/10.1016/0009-9236(95)90069-1

20 June 2024

Robert J Straka

1

object named as

R. J. Straka

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7628180

20 June 2024

author name string

S. R. Hansen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7628180

20 June 2024

P. F. Walker

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7628180

20 June 2024

language of work or name

0 references

publication date

1 July 1995

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

58

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

29-34

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI)

3

1 reference

10.1016/0009-9236(95)90069-1

https://api.crossref.org/works/10.1016/0009-9236(95)90069-1

20 June 2024

Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease

4

1 reference

10.1016/0009-9236(95)90069-1

https://api.crossref.org/works/10.1016/0009-9236(95)90069-1

20 June 2024

Debrisoquin oxidation genotype and susceptibility to lung cancer

5

1 reference

10.1016/0009-9236(95)90069-1

https://api.crossref.org/works/10.1016/0009-9236(95)90069-1

20 June 2024

Interethnic variation of drug metabolism

6

1 reference

10.1016/0009-9236(95)90069-1

https://api.crossref.org/works/10.1016/0009-9236(95)90069-1

20 June 2024

Determination of dextromethorphan and its O-demethylated metabolite from urine

7

1 reference

10.1016/0009-9236(95)90069-1

https://api.crossref.org/works/10.1016/0009-9236(95)90069-1

20 June 2024

Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin

8

1 reference

10.1016/0009-9236(95)90069-1

https://api.crossref.org/works/10.1016/0009-9236(95)90069-1

20 June 2024

Utility of a one-point (3-hour postdose) plasma metabolic ratio as a phenotyping test using metoprolol in two east Asian populations

9

1 reference

10.1016/0009-9236(95)90069-1

https://api.crossref.org/works/10.1016/0009-9236(95)90069-1

20 June 2024

Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations

10

1 reference

10.1016/0009-9236(95)90069-1

https://api.crossref.org/works/10.1016/0009-9236(95)90069-1

20 June 2024

A population and familial study of the defective alicyclic hydroxylation of debrisoquine among Egyptians

11

1 reference

10.1016/0009-9236(95)90069-1

https://api.crossref.org/works/10.1016/0009-9236(95)90069-1

20 June 2024

The polymorphic 4-hydroxylation of debrisoquine in a Saudi arab population

12

1 reference

10.1016/0009-9236(95)90069-1

https://api.crossref.org/works/10.1016/0009-9236(95)90069-1

20 June 2024

Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations

13

1 reference

10.1016/0009-9236(95)90069-1

https://api.crossref.org/works/10.1016/0009-9236(95)90069-1

20 June 2024

A study of the debrisoquine hydroxylation polymorphism in a Nigerian population

14

1 reference

10.1016/0009-9236(95)90069-1

https://api.crossref.org/works/10.1016/0009-9236(95)90069-1

20 June 2024

Metoprolol and debrisoquin metabolism in Nigerians: lack of evidence for polymorphic oxidation

15

1 reference

10.1016/0009-9236(95)90069-1

https://api.crossref.org/works/10.1016/0009-9236(95)90069-1

20 June 2024

Dissociation of co-regulatory control of debrisoquin/phenformin and sparteine oxidation in Ghanaians

16

1 reference

10.1016/0009-9236(95)90069-1

https://api.crossref.org/works/10.1016/0009-9236(95)90069-1

20 June 2024

Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin-oxidation and N-acetylation phenotypes in children

17

1 reference

10.1016/0009-9236(95)90069-1

https://api.crossref.org/works/10.1016/0009-9236(95)90069-1

20 June 2024

Lower prevalence of the debrisoquin oxidative poor metabolizer phenotype in American black versus white subjects

18

1 reference

10.1016/0009-9236(95)90069-1

https://api.crossref.org/works/10.1016/0009-9236(95)90069-1

20 June 2024

Assessment of the debrisoquin and dextromethorphan phenotyping tests by gaussian mixture distributions analysis.

19

1 reference

10.1016/0009-9236(95)90069-1

https://api.crossref.org/works/10.1016/0009-9236(95)90069-1

20 June 2024

Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation

20

1 reference

10.1016/0009-9236(95)90069-1

https://api.crossref.org/works/10.1016/0009-9236(95)90069-1

20 June 2024

A family study of genetic and environmental factors determining polymorphic hydroxylation of debrisoquin

21

1 reference

10.1016/0009-9236(95)90069-1

https://api.crossref.org/works/10.1016/0009-9236(95)90069-1

20 June 2024

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

22

1 reference

10.1016/0009-9236(95)90069-1

https://api.crossref.org/works/10.1016/0009-9236(95)90069-1

20 June 2024

Identifiers

10.1016/0009-9236(95)90069-1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34720813&oldid=2184311591"